The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 mice
Autor: | Forny Germano, Leticia, Koehler, Jacqueline A., Baggio, Laurie L., Cui, Fiona, Wong, Chi Kin, Rittig, Nikolaj, Cao, Xiemin, Matthews, Dianne, Drucker, Daniel J. |
---|---|
Zdroj: | In Molecular Metabolism November 2024 89 |
Databáze: | ScienceDirect |
Externí odkaz: |